Form D · Biotechnology
Adela, Inc.
Foster City, CA · CIK 0001852167
Offering snapshot reported Oct 19, 2026 · SEC filing
- Reported sold
- $12M Offering amount: $12M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 2, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 19, 2026 | Initial | $12,000,000 | No comparison | 5 | SEC filing |
| Apr 23, 2026 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Jul 8, 2025 | Initial | $25,425,442 | No comparison | 9 | SEC filing |
| Jul 29, 2024 | Amendment | $48,540,780 | $20,508,787vs Aug 11, 2023 | 11 | SEC filing |
| Feb 14, 2024 | Initial | $1,187,700 | No comparison | 2 | SEC filing |
| Feb 14, 2024 | Initial | $3,296,554 | No comparison | 3 | SEC filing |
| Aug 11, 2023 | Initial | $28,031,993 | No comparison | 8 | SEC filing |
| Mar 31, 2021 | Initial | $29,999,988 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-601738
Convertible promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversion
Source: Form D, filed Oct 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lisa Alderson | Director, Executive |
| David Bonita | Director |
| Scott Bratman | Executive |
| Paul Brown | Director |
| Daniel De Carvalho | Executive |
| Daniel Diniz De Carvalho | Executive |
| Andrew El Bardissi | Director |
| Anne Renee Hartman | Executive |
| Anne Renee Hartman Feldman | Executive |
| Priscilla Huang | Executive |
| Maneesh Jain | Director |
| Karla Jarvis | Executive |
| Abraham Kometz | Director |
| Lindsay Mateo | Director, Executive |
| Christopher Parker | Executive |
| David Scheer | Director, Executive |
| Robert Weisskoff | Director |
| Alan Williams | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
353 Hatch Drive
Foster City, CA, 94404
Phone: (888) 210-1773
Foster City, CA, 94404
Phone: (888) 210-1773